Year archive

Galapagos NV — 2015 filings

All 187 regulatory filings released by Galapagos NV (GLPG) in 2015, sourced directly from the official regulator.

187 Filings

2015 Period

2015 filings (187)

Filing	Released	Lang
Galapagos receives transparency notification from Wellington Management Group LLP Major Shareholding Notification	2015-12-23	English
Galapagos receives transparency notification from Wellington Management Group LLP Major Shareholding Notification	2015-12-23	English
Galapagos creates new warrant plans Share Issue/Capital Change	2015-12-23	English
Galapagos creates new warrant plans Share Issue/Capital Change	2015-12-23	English
6-K Filing Foreign Filer Report	2015-12-23	English
6-K Filing Foreign Filer Report	2015-12-23	English
Wellington TP NL FINAL.pdf Major Shareholding Notification	2015-12-22	Dutch
S-8 Filing Registration Form	2015-12-22	English
GALAPAGOS EN GILEAD KONDIGEN WERELDWIJDE SAMENWERKING AAN OM FILGOTINIB TE ONTWIKKELEN VOOR DE BEHANDELING VAN REUMA EN ANDERE ONTSTEKINGSZIEKTES Regulatory Filings	2015-12-17	Dutch
6-K Filing Foreign Filer Report	2015-12-17	English
6-K Filing Foreign Filer Report	2015-12-15	English
6-K Filing Foreign Filer Report	2015-12-15	English
Filgotinib meets primary endpoint in phase 2 study in patients with moderate to severe Crohn's disease Earnings Release Q4 2015	2015-12-08	English
Filgotinib meets primary endpoint in phase 2 study in patients with moderate to severe Crohn's disease Earnings Release Q4 2015	2015-12-08	English
Galapagos increases share capital through warrant exercises Share Issue/Capital Change	2015-12-07	English
Galapagos increases share capital through warrant exercises Share Issue/Capital Change	2015-12-07	English
Filgotinib bereikt primaire eindpunt in Fase 2 studie bij patienten met matige tot ernstige ziekte van Crohn Earnings Release Q4 2015	2015-12-07	Dutch
Share capital increase 4 december 2015_NL.pdf Share Issue/Capital Change	2015-12-04	Dutch
6-K Filing Foreign Filer Report	2015-11-24	English
Invitation to the Special Shareholders' Meeting of Galapagos on 22 December 2015 AGM Information	2015-11-23	English
Invitation to the Special Shareholders' Meeting of Galapagos on 22 December 2015 AGM Information	2015-11-23	English
Galapagos initiates Phase 1 First-in-Human study with GLPG1972, receives €3.5 million milestone from Servier Regulatory Filings	2015-11-20	English
6-K Filing Foreign Filer Report	2015-11-20	English
SGM 22 December 2015 - Proxy Form.pdf AGM Information	2015-11-20	Dutch
SGM 22 December 2015 - Attendance Notification Form.pdf AGM Information	2015-11-20	Dutch
SGM 22 December 2015 - Shares and Voting Rights.pdf Share Issue/Capital Change	2015-11-20	Dutch
SGM 22 December 2015 - Convening Notice - E.PDF AGM Information	2015-11-20	English
SGM 22 December 2015 - Convening Notice - D.PDF AGM Information	2015-11-20	Dutch
Galapagos start Fase 1 studie met GLGP1972 en ontvangt €3,5 miljoen van Servier Regulatory Filings	2015-11-20	Dutch
6-K Filing Foreign Filer Report	2015-11-13	English
6-K Filing Foreign Filer Report	2015-11-13	English
6-K Filing Foreign Filer Report	2015-11-13	English
6-K Filing Foreign Filer Report	2015-11-13	English
6-K Filing Foreign Filer Report	2015-11-13	English
Derde kwartaal 2015.pdf Interim / Quarterly Report 9M 2015	2015-11-12	Dutch
Galapagos kaspositie van €374 M na derde kwartaal 2015 Earnings Release 9M 2015	2015-11-12	Dutch
Galapagos builds on strong profile of filgotinib in 7 presentations at ACR 2015 Regulatory Filings	2015-11-09	English
Galapagos builds on strong profile of filgotinib in 7 presentations at ACR 2015 Regulatory Filings	2015-11-09	English
Dr. Christine Mummery treedt toe tot Raad van Bestuur van Galapagos Board/Management Information	2015-11-04	Dutch
Dr. Christine Mummery treedt toe tot Raad van Bestuur van Galapagos Board/Management Information	2015-11-04	Dutch
6-K Filing Foreign Filer Report	2015-10-20	English
6-K Filing Foreign Filer Report	2015-10-20	English
6-K Filing Foreign Filer Report	2015-10-20	English
Galapagos ontwikkelt combinatietherapie voor taaislijmziekte Regulatory Filings	2015-10-15	Dutch
Kandidaat taaislijmziektemedicijn GLPG1837 toont positieve Fase 1 resultaten Earnings Release Q4 2015	2015-10-09	Dutch
Kandidaat taaislijmziektemedicijn GLPG1837 toont positieve Fase 1 resultaten Earnings Release Q4 2015	2015-10-09	Dutch
Galapagos presenteert veelbelovende bevindingen in taaislijmziekteprogramma's op NACFC 2015 Regulatory Filings	2015-10-08	Dutch
Galapagos presenteert veelbelovende bevindingen in taaislijmziekteprogramma's op NACFC 2015 Regulatory Filings	2015-10-08	Dutch
Galapagos presenteert veelbelovende bevindingen in taaislijmziekteprogramma’s op NACFC 2015 Regulatory Filings	2015-10-08	Dutch
6-K Filing Foreign Filer Report	2015-10-06	English
Galapagos raises €1.2 million through warrant exercises Share Issue/Capital Change	2015-10-05	English
Galapagos raises €1.2 million through warrant exercises Share Issue/Capital Change	2015-10-05	English
Share capital increase 25 September 2015_NL.pdf Share Issue/Capital Change	2015-10-02	Dutch
Galapagos to advance filgotinib to Phase 3 in rheumatoid arthritis Regulatory Filings	2015-09-28	English
6-K Filing Foreign Filer Report	2015-09-28	English
Galapagos plant start fase 3 van filgotinib in reuma Earnings Release Q3 2015	2015-09-25	Dutch
Galapagos presents promising pre-clinical and Phase 1 results with autotaxin inhibitor GLPG1690 at ERS Regulatory Filings	2015-09-22	English
Galapagos presents promising pre-clinical and Phase 1 results with autotaxin inhibitor GLPG1690 at ERS Earnings Release Q3 2015	2015-09-22	English
6-K Filing Foreign Filer Report	2015-08-12	English
DARWIN 2 24-week monotherapy data in RA confirm previous results and support best-in-class potential for filgotinib Earnings Release Q3 2015	2015-08-11	English
DARWIN 2 24-weken monotherapie gegevens in reuma bevestigen eerdere resultaten en ondersteunen het best-in-class potentieel van filgotinib Earnings Release Q3 2015	2015-08-10	Dutch
Patient recruitment completed in FITZROY Phase 2 Crohn's disease study with filgotinib Earnings Release Q3 2015	2015-08-06	English
Patient recruitment completed in FITZROY Phase 2 Crohn's disease study with filgotinib Earnings Release Q3 2015	2015-08-06	English
Galapagos on track to deliver on pipeline in second half 2015 Interim / Quarterly Report H1 2015	2015-08-06	English
Galapagos on track to deliver on pipeline in second half 2015 Interim / Quarterly Report H1 2015	2015-08-06	English
6-K Filing Foreign Filer Report	2015-08-06	English
Galapagos rondt werving van patiënten af in FITZROY Fase 2 studie met filgotinib in de ziekte van Crohn Regulatory Filings	2015-08-06	Dutch
Galapagos op koers om resultaten voor pijplijn te leveren in tweede halfjaar 2015 Interim / Quarterly Report H1 2015	2015-08-05	Dutch
Half-year report 2015.pdf Interim / Quarterly Report H1 2015	2015-08-05	English
Halfjaarverslag 2015.pdf Interim / Quarterly Report H1 2015	2015-08-05	Dutch
6-K Filing Foreign Filer Report	2015-07-31	English
Galapagos' selective JAK1 inhibitor filgotinib meets key efficacy endpoints, shows ACR70 responses up to 39%, and maintains safety profile after 24 weeks of treatment in DARWIN 1 Phase 2B study Earnings Release Q3 2015	2015-07-30	English
Galapagos' selective JAK1 inhibitor filgotinib meets key efficacy endpoints, shows ACR70 responses up to 39%, and maintains safety profile after 24 weeks of treatment in DARWIN 1 Phase 2B study Earnings Release Q3 2015	2015-07-30	English
Galapagos’ selectieve JAK1 remmer filgotinib behaalt alle belangrijke eindpunten voor werkzaamheid Earnings Release Q3 2015	2015-07-30	Dutch
Galapagos licenses Organoid Technology from the HUB foundation for use in cystic fibrosis and IBD research Regulatory Filings	2015-07-15	English
Galapagos licenses Organoid Technology from the HUB foundation for use in cystic fibrosis and IBD research Regulatory Filings	2015-07-15	English
6-K Filing Foreign Filer Report	2015-06-24	English
Galapagos raises €4.4 million through warrant exercises Share Issue/Capital Change	2015-06-22	English
Galapagos raises €4.4 million through warrant exercises Share Issue/Capital Change	2015-06-22	English
6-K Filing Foreign Filer Report	2015-06-19	English
Share capital increase 19 June 2015_NL_FINAL.pdf Share Issue/Capital Change	2015-06-19	Dutch
Galapagos completes recruitment for ORIGIN Phase 2 trial with GLPG1205 in ulcerative colitis patients Regulatory Filings	2015-06-18	English
Galapagos completes recruitment for ORIGIN Phase 2 trial with GLPG1205 in ulcerative colitis patients Regulatory Filings	2015-06-18	English
SC 13G Filing Major Shareholding Notification	2015-06-18	English
Galapagos rondt werving van patiënten af voor ORIGIN Fase 2 klinische studie met GLPG1205 bij colitis ulcerosa patiënten Regulatory Filings	2015-06-18	Dutch
6-K Filing Foreign Filer Report	2015-06-16	English
AbbVie and Galapagos present cystic fibrosis corrector and potentiator screening approach at ECFS conference Investor Presentation	2015-06-15	English
AbbVie and Galapagos present cystic fibrosis corrector and potentiator screening approach at ECFS conference Investor Presentation	2015-06-15	English
AbbVie en Galapagos presenteren resultaten taaislijmziekte (CF) onderzoek op ECFS conferentie Regulatory Filings	2015-06-15	Dutch
6-K Filing Foreign Filer Report	2015-06-11	English
Galapagos DARWIN 1 and 2 studies have completed 24 weeks of treatment Regulatory Filings	2015-06-10	English
Galapagos DARWIN 1 and 2 studies have completed 24 weeks of treatment Regulatory Filings	2015-06-10	English
Galapagos DARWIN 1 en 2 patiëntenstudies van 24 weken afgerond Earnings Release FY 2015	2015-06-10	Dutch
S-8 Filing Registration Form	2015-05-29	English
6-K Filing Foreign Filer Report	2015-05-28	English
Galapagos receives transparency notifications Major Shareholding Notification	2015-05-27	English
Galapagos receives transparency notifications Major Shareholding Notification	2015-05-27	English
Canaan transparency notices NL.pdf Major Shareholding Notification	2015-05-26	Dutch
Galapagos announces capital increase Share Issue/Capital Change	2015-05-20	English
Galapagos announces capital increase Share Issue/Capital Change	2015-05-20	English
Galapagos announces closing of NASDAQ IPO Share Issue/Capital Change	2015-05-20	English
Galapagos announces closing of NASDAQ IPO Share Issue/Capital Change	2015-05-20	English
6-K Filing Foreign Filer Report	2015-05-19	English
Galapagos kondigt afronding aan van NASDAQ IPO transactie Share Issue/Capital Change	2015-05-19	Dutch
capital increase NL.pdf Share Issue/Capital Change	2015-05-19	Dutch
Galapagos announces full exercise of underwriters' option to purchase additional shares Share Issue/Capital Change	2015-05-18	English
Galapagos announces full exercise of underwriters' option to purchase additional shares Share Issue/Capital Change	2015-05-18	English
Galapagos kondigt aan dat de underwriters de greenshoe optie volledig uitgeoefend hebben Share Issue/Capital Change	2015-05-18	Dutch
Galapagos raises $275 million gross proceeds with NASDAQ IPO Share Issue/Capital Change	2015-05-14	English
Galapagos raises $275 million gross proceeds with NASDAQ IPO Share Issue/Capital Change	2015-05-14	English
424B4 Filing Prospectus	2015-05-14	English
Galapagos beursgang op NASDAQ voor een bruto-opbrengst van $275 miljoen Share Issue/Capital Change	2015-05-14	Dutch
FWP Filing Regulatory Filings	2015-05-12	English
Galapagos verhoogt grootte van aandelenuitgifte tot $250 miljoen Share Issue/Capital Change	2015-05-12	Dutch
Johnson & Johnson Innovation – JJDC Inc. heeft het voornemen om voor $25 miljoen in te schrijven op de Galapagos’ aandelenuitgifte Share Issue/Capital Change	2015-05-07	Dutch
Galapagos announces launch of proposed global offering Share Issue/Capital Change	2015-05-06	English
Galapagos announces launch of proposed global offering Share Issue/Capital Change	2015-05-06	English
Galapagos listed 10 years on Euronext Amsterdam and Brussels Regulatory Filings	2015-05-06	English
Galapagos listed 10 years on Euronext Amsterdam and Brussels Report Publication Announcement	2015-05-06	English
Galapagos 10 jaar Euronext notering in Amsterdam en Brussel Regulatory Filings	2015-05-06	Dutch
Galapagos kondigt start voorgenomen aandelenuitgifte aan, met het voornemen van AbbVie om in te schrijven voor $30M Share Issue/Capital Change	2015-05-06	Dutch
BNP Paribas notify of 4.8% shareholding in Galapagos Major Shareholding Notification	2015-05-01	English
BNP Paribas notify of 4.8% shareholding in Galapagos Major Shareholding Notification	2015-05-01	English
Galapagos creates new warrant plan Remuneration Information	2015-05-01	English
Galapagos creates new warrant plan Share Issue/Capital Change	2015-05-01	English
Galapagos creëert nieuw warrantplan Remuneration Information	2015-05-01	Dutch
BNP Paribas trans notice apr 2015 _NL_FINAL.pdf Major Shareholding Notification	2015-05-01	Dutch
Filgotinib as monotherapy also hits primary endpoint in DARWIN 2 trial Earnings Release Q2 2015	2015-04-28	English
Filgotinib as monotherapy also hits primary endpoint in DARWIN 2 trial Earnings Release Q2 2015	2015-04-28	English
Filgotinib behaalt ook als monotherapie het primaire eindpunt in de DARWIN 2 reumatoïde artritis studie Earnings Release Q2 2015	2015-04-27	Dutch
Galapagos files registration statement in the United States for a proposed global offering Capital/Financing Update	2015-04-16	English
Galapagos files registration statement in the United States for a proposed global offering Capital/Financing Update	2015-04-16	English
Galapagos' JAK1 inhibitor filgotinib (GLPG0634) meets primary and other key efficacy endpoints after 12 weeks of treatment in DARWIN 1 Phase 2B study Earnings Release Q2 2015	2015-04-15	English
Galapagos' JAK1 inhibitor filgotinib (GLPG0634) meets primary and other key efficacy endpoints after 12 weeks of treatment in DARWIN 1 Phase 2B study Earnings Release Q2 2015	2015-04-15	English
Galapagos dient registratiedocument in de Verenigde Staten in voor beoogde uitgifte Capital/Financing Update	2015-04-15	Dutch
Galapagos’ JAK1 remmer filgotinib (GLPG0634) behaalt het primaire en de andere belangrijke werkzaamheid eindpunten na 12 weken behandeling in de DARWIN 1 Fase 2B studie Regulatory Filings	2015-04-14	Dutch
Publication of Annual Report 2014 and invitation to the Annual Shareholders' Meeting to be held on 28 April 2015 AGM Information	2015-03-30	English
Publication of Annual Report 2014 and invitation to the Annual Shareholders' Meeting to be held on 28 April 2015 AGM Information	2015-03-30	English
Galapagos raises €5.8 million through warrant exercises, Board and Executive Committee members invest Share Issue/Capital Change	2015-03-27	English
Galapagos raises €5.8 million through warrant exercises, Board and Executive Committee members invest Share Issue/Capital Change	2015-03-27	English
JAARVERSLAG 2014.pdf Annual Report FY 2014	2015-03-27	Dutch
AGM_28_April_2015_-_Auditors_Report_-_Non-Consolidated_Financial_Statementds_D.pdf Audit Report / Information FY 2014	2015-03-27	Dutch
AGM_28_April_2015_-_Shares_and_Voting_Rights.pdf Share Issue/Capital Change	2015-03-27	Dutch
AGM_28_April_2015_-_Proxy_Form.pdf AGM Information	2015-03-27	Dutch
AGM_28_April_2015_-_Non-Consolidated_Financial_Statements.pdf Annual Report FY 2014	2015-03-27	Dutch
AGM_28_April_2015_-_Attendance_Notification_Form.pdf AGM Information	2015-03-27	Dutch
AGM 28 April 2015 - Convening Notice - E [G0147962-v1.0].pdf AGM Information	2015-03-27	English
AGM 28 April 2015 - Convening Notice - D [G0147968-v1.1].pdf AGM Information	2015-03-27	Dutch
AGM Invitation & Annual Report 2014 Report Publication Announcement	2015-03-27	English
Uitnodiging AV en Jaarverslag 2014 Report Publication Announcement	2015-03-27	Dutch
ANNUAL REPORT 2014.pdf Annual Report FY 2014	2015-03-27	English
JAARVERSLAG 2014.pdf Annual Report FY 2014	2015-03-27	Dutch
Share capital increase NL_FINAL.pdf Capital/Financing Update	2015-03-27	Dutch
Galapagos regains rights to GLPG1690, announces end of alliance with Janssen Regulatory Filings	2015-03-17	English
Galapagos regains rights to GLPG1690, announces end of alliance with Janssen Regulatory Filings	2015-03-17	English
Galapagos krijgt rechten terug voor GLPG1690, kondigt het beëindigen van alliantie met Janssen aan M&A Activity	2015-03-17	Dutch
Galapagos to be included in Amsterdam Midcap Index Regulatory Filings	2015-03-06	English
Galapagos to be included in Amsterdam Midcap Index Regulatory Filings	2015-03-06	English
Galapagos reports 2014 financial results Earnings Release FY 2014	2015-03-06	English
Galapagos reports 2014 financial results Earnings Release FY 2014	2015-03-06	English
Galapagos wordt in AMX index opgenomen Regulatory Filings	2015-03-06	Dutch
FY2014_FINAL NL.pdf Earnings Release FY 2014	2015-03-06	Dutch
Galapagos reports that the last patient in DARWIN 1 has completed 12 weeks of treatment Regulatory Filings	2015-02-23	English
Galapagos reports that the last patient in DARWIN 1 has completed 12 weeks of treatment Regulatory Filings	2015-02-23	English
Galapagos reports positive Phase 1 results for GLPG1690 Earnings Release Q1 2015	2015-02-16	English
Galapagos rapporteert positieve resultaten in Fase 1 studie met GLPG1690 Earnings Release Q1 2015	2015-02-16	Dutch
Galapagos rapporteert positieve resultaten in Fase 1 studie met GLPG1690 Environmental & Social Information	2015-02-16	Dutch
Galapagos receives €1.6 million IWT grant for hepatitis B program Regulatory Filings	2015-02-11	English
Galapagos receives €1.6 million IWT grant for hepatitis B program Regulatory Filings	2015-02-11	English
Galapagos ontvangt €1,6 miljoen subsidie van het IWT voor onderzoek naar hepatitis B Regulatory Filings	2015-02-11	Dutch
BNP Paribas notify of 5.08% shareholding in Galapagos Major Shareholding Notification	2015-02-09	English
BNP Paribas notify of 5.08% shareholding in Galapagos Major Shareholding Notification	2015-02-09	English
BNP Paribas geeft kennis van deelneming van 5,08% in Galapagos Major Shareholding Notification	2015-02-09	Dutch
2015_05-NL.pdf Major Shareholding Notification	2015-02-09	Dutch
Galapagos receives €2.5 million IWT grant for antibiotic research Regulatory Filings	2015-01-22	English
Galapagos receives €2.5 million IWT grant for antibiotic research Regulatory Filings	2015-01-22	English
Delta Lloyd notify of 4.96% shareholding in Galapagos Major Shareholding Notification	2015-01-22	English
Delta Lloyd notify of 4.96% shareholding in Galapagos Major Shareholding Notification	2015-01-22	English
Galapagos ontvangt €2,5 miljoen subsidie voor onderzoek naar nieuwe antibiotica Regulatory Filings	2015-01-22	Dutch
Delta Lloyd medlt 4,96% belang in Galapagos Major Shareholding Notification	2015-01-21	Dutch
TR-1BE_NL_Delta Lloyd_Galapagos_16012014.pdf Major Shareholding Notification	2015-01-21	Dutch
Vicki Sato resigns from Galapagos Board Board/Management Information	2015-01-09	English
Vicki Sato resigns from Galapagos Board Board/Management Information	2015-01-09	English
Galapagos starts Phase 2 trial with GLPG1205 in ulcerative colitis patients Regulatory Filings	2015-01-08	English
Galapagos starts Phase 2 trial with GLPG1205 in ulcerative colitis patients Investor Presentation	2015-01-08	English
Vicki Sato treedt af als lid Raad van Bestuur van Galapagos Board/Management Information	2015-01-08	Dutch
Galapagos start Fase 2 klinische studie met GLPG1205 bij colitis ulcerosa patiënten Legal Proceedings Report	2015-01-08	Dutch

Filings by year

2026 99 filings
2025 162 filings
2024 118 filings
2023 121 filings
2022 167 filings
2021 183 filings
2020 156 filings
2019 324 filings
2018 205 filings
2017 196 filings
2016 217 filings
2015 187 filings
2014 183 filings
2013 142 filings
2012 105 filings
2011 124 filings
2010 42 filings
2009 39 filings
2008 31 filings
2007 27 filings
2006 15 filings
2005 12 filings